| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/23/2005 | EP1507758A2 Indole derivatives and their use as ligands for cb2 receptors |
| 02/23/2005 | EP1507756A1 Ccr9 inhibitors and methods of use thereof |
| 02/23/2005 | EP1507555A2 Induction of antigen specific immunologic tolerance |
| 02/23/2005 | EP1507554A1 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
| 02/23/2005 | EP1507544A1 Active fraction having anti-cancer and anti-metastasis isolated from leaves and stems of ginseng |
| 02/23/2005 | EP1507539A1 Hormone replacement therapy using a combination of conjugated estrogens and trimegestone |
| 02/23/2005 | EP1507535A1 Pyrimidine-2,4,6-trione metallo-proteinase inhibitors |
| 02/23/2005 | EP1507531A2 Stable pharmaceutical compositions of desloratadine |
| 02/23/2005 | EP1507528A2 Methods for using jnk inhibitors for treating or preventing disease-related wasting |
| 02/23/2005 | EP1507517A1 Microparticles bearing cells and active substances |
| 02/23/2005 | EP1317421B1 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/23/2005 | EP1286986B1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain |
| 02/23/2005 | EP1058544B1 Inhibition of tnf activity with compositions comprising heparin and soluble tnf recpetors |
| 02/23/2005 | EP1029549B1 Formulation of nucleic acids and acemannan |
| 02/23/2005 | EP0689454B2 Vaccine compositions containing 3-o deacylated monophosphoryl lipid a |
| 02/23/2005 | CN1585900A Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin |
| 02/23/2005 | CN1585777A 肝脏x受体激动剂 Liver x receptor agonist |
| 02/23/2005 | CN1585772A Chemokine receptor antagonists and methods of use thereof |
| 02/23/2005 | CN1585771A Polycyclic guanine derivative phosphodiesterase V inhibitors |
| 02/23/2005 | CN1585763A Piperidine derivatives and their use as modulators of chemokine receptor activity especially CCR5 |
| 02/23/2005 | CN1585755A Benzamide and heteroarylamide as P2X7 receptor antagonists |
| 02/23/2005 | CN1585749A Cannabinoid receptor ligands |
| 02/23/2005 | CN1585745A Hydroxyfattysulfonic acid analogs |
| 02/23/2005 | CN1585648A Enamel matrix protein compositions for modulating immune response |
| 02/23/2005 | CN1585641A Hydrazono-malonitriles |
| 02/23/2005 | CN1585638A Linked biaryl compounds |
| 02/23/2005 | CN1585633A Phenethanolamine derivatives for treatment of respiratory diseases |
| 02/23/2005 | CN1583753A Dioxazole pyrimidine nucleotide compounds with function of releasing NO and its use in pharmaceutics |
| 02/23/2005 | CN1583747A Pterin mononitrogen monoxide synthase inhibitor |
| 02/23/2005 | CN1583745A Amino biological pterin derivative and pharmaceutical use thereof |
| 02/23/2005 | CN1583163A Preparing procedure for enteric soluble capsules of transfer factor |
| 02/23/2005 | CN1583162A Injection of donkey hide gelatin and its preparation |
| 02/23/2005 | CN1583144A Chinese medicinal preparation for allergic reaction |
| 02/23/2005 | CN1583068A Health care food for regulating blood sugar and immunologic function |
| 02/23/2005 | CN1582980A Chinese medicinal composition for improving sleep and relaxing fatigue and its preparation |
| 02/23/2005 | CN1582964A Sheep fetus health care products and their products |
| 02/23/2005 | CN1582956A Composition of mycobacterium polysaccharide and its preparation |
| 02/23/2005 | CN1582945A Powder injections of composite monoammonium glycyrrhizinate and their preparation |
| 02/23/2005 | CN1582931A Oral sustained releasing micro-tablets of tuduranine and their preparation |
| 02/23/2005 | CN1582906A Dimedrol drops and their preparation |
| 02/23/2005 | CN1190437C Pteridine compounds for treatment of psoriasis |
| 02/22/2005 | US6858740 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 02/22/2005 | US6858724 Used as anti-tumor agents and/or anti-HIV agents having immunostimulate activities; inversion of OR2 to OR1 in glucopyranose derivtives (R1= H or acetyl, R2= a leaving group such as tosylate, trifluoromesylate or methanesulfonate |
| 02/22/2005 | US6858714 Cyclic GMP phosphodiesterase |
| 02/22/2005 | US6858626 Cyclic hydroxamic acid as metalloproteinase inhibitors |
| 02/22/2005 | US6858620 For therapy of male erectile dysfunction; female arousal disorder |
| 02/22/2005 | US6858615 Phenyl guanidine sodium channel blockers |
| 02/22/2005 | US6858610 Autoimmune disease; antiinflammatory agents |
| 02/22/2005 | US6858609 Substituted diamino-1,3,5-triazine derivatives |
| 02/22/2005 | US6858603 Acetindine derivatives, their preparation and medicaments containing them |
| 02/22/2005 | US6858597 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase |
| 02/22/2005 | US6858596 Aqueous suspension of Fluticasone furoate; respiratory tract disorders; asthma, COPD; antiinflammatory, antiallergen; nasal inhaler |
| 02/22/2005 | US6858593 Composition in which the crystal lattice is stabilised by the presence of a guest molecule, characterised in the crystalline composition is of space group P212121 having unit cell dimensions of about 7. 6+-0.6 Angstrom , 12.7+-0.7 Angstrom , |
| 02/22/2005 | US6858407 Nucleotide sequences coding polypetide for use in the treatment, prevention and diagnosis of gastrointestinal and apoptosis disorders |
| 02/22/2005 | US6858222 Fabrication of drug loaded biodegradable polymer fibers |
| 02/22/2005 | US6858210 For inducing tolerance in an individual; bind to anti-cardiolipin ( beta 2GPI-dependent antiphospholipid) |
| 02/22/2005 | CA2438055A1 Treatment of allergic rhinitis |
| 02/22/2005 | CA2236256C A pharmaceutical composition for the treatment of autoimmune diseases |
| 02/22/2005 | CA2185352C Novel muteins of ifn-.beta. |
| 02/22/2005 | CA2093022C Targeted immunostimulation with bispecific reagents |
| 02/17/2005 | WO2005014770A1 Allergen reducing agent, composition containing same and method for reducing allergen |
| 02/17/2005 | WO2005014653A2 Humanized chicken antibodies |
| 02/17/2005 | WO2005014603A1 Phosphinane compounds with immunomodulating activity |
| 02/17/2005 | WO2005014599A1 Imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of bruton’s tyrosine kinase by such compounds |
| 02/17/2005 | WO2005014576A1 Isoquinolinone derivative, process for producing the same and use thereof |
| 02/17/2005 | WO2005014572A1 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 02/17/2005 | WO2005014567A1 Mycophenolic acid bismuth salt |
| 02/17/2005 | WO2005014525A2 Bi-aryl compound having immunosuppressive activity |
| 02/17/2005 | WO2005014110A1 Cpg-packaged liposomes |
| 02/17/2005 | WO2005014036A1 Targeted therapeutic vaccine against p-glycoprotein 170 for inhibiting multi-drug resistance in the treatment of cancers |
| 02/17/2005 | WO2005014009A1 Glycyrrhizin high-concentration preparation |
| 02/17/2005 | WO2005013991A1 Dry syrup containing loratadine |
| 02/17/2005 | WO2005013986A1 Pyridylpyrrole derivatives active as kinase inhibitors |
| 02/17/2005 | WO2005013966A1 Macrophage activation inhibitor |
| 02/17/2005 | WO2005013958A1 Histone deacetylase inhibitors as immunosuppressants |
| 02/17/2005 | WO2005013938A1 Process for producing drug ultramicroparticle and apparatus therefor |
| 02/17/2005 | WO2004081028A3 Allergen peptide fragments and use thereof |
| 02/17/2005 | WO2003099192A8 Bis-aromatic alkanols |
| 02/17/2005 | WO2003080568A3 Probucol derivatives |
| 02/17/2005 | WO2003025131A3 Protein modification and maintenance molecules |
| 02/17/2005 | WO2002074913A3 Nucleic acid-associated proteins |
| 02/17/2005 | US20050038259 Elastase release inhibitors; such as 19-(1H-tetrazol-5-yl)nonadec-6-en-5-ol |
| 02/17/2005 | US20050038243 2, 4-pyrimidinediamine compounds and their uses |
| 02/17/2005 | US20050038095 Azolylbenzamides and analogues and their use for treating osteoporosis |
| 02/17/2005 | US20050038084 Phenylalanine enamide derivatives |
| 02/17/2005 | US20050038069 Tumor necrosis factor antagonist; antiinflammatory agents; such as 2-Cyclopropyl-4-(3,5-dimethyl-4-pyridylmethoxy)-7-methoxy-3H-benzimidazole |
| 02/17/2005 | US20050038061 6-Aminomorphinane derivatives, method for production and use thereof |
| 02/17/2005 | US20050038050 Therapeutic treatment of autoimmune disease, transplant rejection, rheumatoid arthritis, by administering 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline |
| 02/17/2005 | US20050038044 For drug resistance disease; side effect reduction; antiinflammatory agents; autoimmune disease |
| 02/17/2005 | US20050038033 use in treating respiratory system disorders such as asthma, incipient asthma and wheezy infant syndrome, chronic or acute bronchoconstriction, chronic bronchitis, small airways obstruction, emphysema, chronic eosinophilic pneumonia, chronic obstructive pulmonary disease, allergies |
| 02/17/2005 | US20050038023 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 02/17/2005 | US20050038014 5'-carbamoyl-1,1' biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 02/17/2005 | US20050038010 Substituted heterocyclic compounds and methods of use |
| 02/17/2005 | US20050037949 Mannose binding lectin and uses thereof |
| 02/17/2005 | US20050037494 Using antisense agents to reduce and/or prevention genic expression associated with cardi-vascular complications; gene therapy |
| 02/17/2005 | US20050037339 Methods of selecting internalizing antibodies |
| 02/17/2005 | US20050037096 Dispersed solid-containing complex carbohydrate |
| 02/17/2005 | US20050037028 Topical antiallergenic cream containing Asian longhorn beetle wastes; animal extracts |
| 02/17/2005 | US20050037014 T helper cell epitopes |
| 02/17/2005 | US20050037009 Methods and reagents for protease inhibition |